Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Advances in the diagnosis of giant cell arteritis.

Ing E, Pagnoux C, Torun N.

Curr Opin Ophthalmol. 2019 Sep 9. doi: 10.1097/ICU.0000000000000616. [Epub ahead of print]

PMID:
31503077
2.

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis.

Rodriguez-Pla A, Warner RL, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Johnson KJ, Merkel PA, Monach PA; Vasculitis Clinical Research Consortium.

J Rheumatol. 2019 Sep 1. pii: jrheum.190093. doi: 10.3899/jrheum.190093. [Epub ahead of print]

PMID:
31474593
3.

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis.

Gribbons KB, Ponte C, Carette S, Craven A, Cuthbertson D, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Quinn KA, Robson JC, Seo P, Sreih AG, Suppiah R, Warrington KJ, Ytterberg SR, Luqmani R, Watts R, Merkel PA, Grayson PC.

Arthritis Care Res (Hoboken). 2019 Aug 23. doi: 10.1002/acr.24055. [Epub ahead of print]

PMID:
31444857
4.

Long-term outcomes of patients with Takayasu arteritis and renal artery involvement: a cohort study.

Baldwin C, Mohammad AJ, Cousins C, Carette S, Pagnoux C, Jayne D.

Rheumatol Adv Pract. 2018 Aug 16;2(2):rky026. doi: 10.1093/rap/rky026. eCollection 2018.

5.

Treatment of systemic necrotizing vasculitides: recent advances and important clinical considerations.

Pagnoux C, Mendel A.

Expert Rev Clin Immunol. 2019 Sep;15(9):939-949. doi: 10.1080/1744666X.2019.1656527. Epub 2019 Aug 26.

PMID:
31414912
6.

Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitis.

Houben E, Mendel A, van der Heijden JW, Simsek S, Bax WA, Carette S, Voskuyl AE, Pagnoux C, Penne EL.

Rheumatology (Oxford). 2019 Jun 26. pii: kez229. doi: 10.1093/rheumatology/kez229. [Epub ahead of print] No abstract available.

PMID:
31243446
7.

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis.

Quinn KA, Gelbard A, Sibley C, Sirajuddin A, Ferrada MA, Chen M, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Merkel PA, Grayson PC.

Rheumatology (Oxford). 2019 Jun 14. pii: kez217. doi: 10.1093/rheumatology/kez217. [Epub ahead of print]

PMID:
31199488
8.

Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitis.

Montante A, Le Bras A, Pagnoux C, Perrodeau E, Ravaud P, Terrier B, Guillevin L, Durand-Zaleski I; French Vasculitis Study Group.

Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):137-143. Epub 2019 May 21.

9.

Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.

Ennis D, Lee JK, Pagnoux C.

Expert Opin Biol Ther. 2019 Jul;19(7):617-630. doi: 10.1080/14712598.2019.1623875. Epub 2019 May 31.

PMID:
31146595
10.

Comments on the giant cell arteritis probability score.

Ing E, Sambhi G, Torun N, Pagnoux C.

Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):150. Epub 2019 May 8. No abstract available.

11.

Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.

Puéchal X, Pagnoux C, Baron G, Lifermann F, Geffray L, Quémeneur T, Saraux JL, Wislez M, Cottin V, Ruivard M, Limal N, Aouba A, Bonnotte B, Néel A, Agard C, Cohen P, Terrier B, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group investigators.

Rheumatology (Oxford). 2019 May 5. pii: kez139. doi: 10.1093/rheumatology/kez139. [Epub ahead of print]

PMID:
31056661
12.

Primary angiitis of the central nervous system: Clinical profiles and outcomes of 45 patients.

Sundaram S, Menon D, Khatri P, Sreedharan SE, Jayadevan ER, Sarma P, Pagnoux C, Sylaja PN.

Neurol India. 2019 Jan-Feb;67(1):105-112. doi: 10.4103/0028-3886.253578.

13.

The incidence of giant cell arteritis in Ontario, Canada.

Ing EB, Lahaie Luna G, Pagnoux C, Baer PA, Wang D, Benard-Seguin E, Godra I, Godra A, Munoz DG, McReelis K, Ten Hove M.

Can J Ophthalmol. 2019 Feb;54(1):119-124. doi: 10.1016/j.jcjo.2018.03.002. Epub 2018 Nov 12.

PMID:
30851765
14.

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.

Tomasson G, Farrar JT, Cuthbertson D, McAlear CA, Ashdown S, Cronholm PF, Dawson J, Gebhart D, Lanier G, Luqmani RA, Milman N, Peck J, Robson JC, Shea JA, Carette S, Khalidi N, Koening CL, Langford CA, Monach PA, Moreland L, Pagnoux C, Specks U, Sreih AG, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

J Rheumatol. 2019 Aug;46(8):928-934. doi: 10.3899/jrheum.171405. Epub 2019 Mar 1.

PMID:
30824648
15.

Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma.

Pagnoux C, Nair P, Xi Y, Khalidi NA, Carette S, Cuthbertson D, Grayson PC, Koening CL, Langford CA, McAlear CA, Moreland LW, Monach PA, Seo P, Specks U, Sreih AG, Ytterberg SR, Tyrrell PN, Merkel PA; Vasculitis Clinical Research Consortium.

Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):40-44. Epub 2019 Jan 14.

16.

Conventional and biological immunosuppressants in vasculitis.

Guillevin L, Mukhtyar C, Pagnoux C, Yates M.

Best Pract Res Clin Rheumatol. 2018 Feb;32(1):94-111. doi: 10.1016/j.berh.2018.07.006. Epub 2018 Aug 22. Review.

PMID:
30526901
17.

Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA.

Nephrol Dial Transplant. 2018 Oct 31. doi: 10.1093/ndt/gfy300. [Epub ahead of print]

PMID:
30380100
18.

Assessment of functional nanomaterials in medical applications: can time mend public and occupational health risks related to the products' fate?

Bressot C, Aubry A, Pagnoux C, Aguerre-Chariol O, Morgeneyer M.

J Toxicol Environ Health A. 2018;81(19):957-973. doi: 10.1080/15287394.2018.1477271. Epub 2018 Oct 12.

PMID:
30311864
19.

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis.

Rhee RL, Holweg CTJ, Wong K, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

PLoS One. 2018 Oct 11;13(10):e0205768. doi: 10.1371/journal.pone.0205768. eCollection 2018.

20.

Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: A comparative study.

de Boysson H, Parienti JJ, Mawet J, Arquizan C, Boulouis G, Burcin C, Naggara O, Zuber M, Touzé E, Aouba A, Bousser MG, Pagnoux C, Ducros A.

Neurology. 2018 Oct 16;91(16):e1468-e1478. doi: 10.1212/WNL.0000000000006367. Epub 2018 Sep 19.

PMID:
30232250
21.

Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease.

Dubash S, Marianayagam T, Tinazzi I, Al-Araimi T, Pagnoux C, Weizman AV, Richette P, Tran Minh ML, Allez M, Singh A, Ciccia F, Hamlin J, Tan AL, Marzo-Ortega H, McGonagle D.

Rheumatology (Oxford). 2019 Jun 1;58(6):963-968. doi: 10.1093/rheumatology/key267.

22.

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Geetha D, Jin Q, Scott J, Hruskova Z, Hanouneh M, Little MA, Tesar V, Seo P, Jayne D, Pagnoux C.

Kidney Int Rep. 2018 May 24;3(5):1039-1049. doi: 10.1016/j.ekir.2018.05.007. eCollection 2018 Sep. Review.

23.

Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry.

Iudici M, Quartier P, Pagnoux C, Merlin E, Agard C, Aouba A, Roblot P, Cohen P, Terrier B, Mouthon L, Guillevin L, Puéchal X; French Vasculitis Study Group.

Autoimmun Rev. 2018 Oct;17(10):984-989. doi: 10.1016/j.autrev.2018.08.001. Epub 2018 Aug 14. Review.

PMID:
30114520
24.

Presentation and Disease Course of Childhood-Onset Versus Adult-Onset Takayasu Arteritis.

Aeschlimann FA, Barra L, Alsolaimani R, Benseler SM, Hebert D, Khalidi N, Laxer RM, Noone D, Pagnoux C, Twilt M, Yeung RSM.

Arthritis Rheumatol. 2019 Feb;71(2):315-323. doi: 10.1002/art.40690. Epub 2018 Dec 29.

PMID:
30101446
25.

Treatment and Long-Term Outcomes of Primary Central Nervous System Vasculitis.

de Boysson H, Arquizan C, Touzé E, Zuber M, Boulouis G, Naggara O, Guillevin L, Aouba A, Pagnoux C.

Stroke. 2018 Aug;49(8):1946-1952. doi: 10.1161/STROKEAHA.118.021878.

PMID:
29986936
26.

Arterial lesions in giant cell arteritis: A longitudinal study.

Kermani TA, Diab S, Sreih AG, Cuthbertson D, Borchin R, Carette S, Forbess L, Koening CL, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Spiera RF, Warrington KJ, Ytterberg SR, Langford CA, Merkel PA, Khalidi NA; Vasculitis Clinical Research Consortium.

Semin Arthritis Rheum. 2019 Feb;48(4):707-713. doi: 10.1016/j.semarthrit.2018.05.002. Epub 2018 May 9.

27.

Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology.

Novick TK, Chen M, Scott J, Cortazar FB, Ayoub I, Little MA, Hruskova Z, Salama AD, Pagnoux C, Geetha D.

Kidney Int Rep. 2018 Feb 21;3(3):671-676. doi: 10.1016/j.ekir.2018.01.012. eCollection 2018 May.

28.

Lower ocular pulse amplitude with dynamic contour tonometry is associated with biopsy-proven giant cell arteritis.

Ing E, Pagnoux C, Tyndel F, Sundaram A, Hershenfeld S, Ranalli P, Chow S, Le T, Lutchman C, Rutherford S, Lam K, Bedi H, Torun N.

Can J Ophthalmol. 2018 Jun;53(3):215-221. doi: 10.1016/j.jcjo.2017.10.027. Epub 2017 Dec 26.

PMID:
29784156
29.

Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry.

Jardel S, Puéchal X, Le Quellec A, Pagnoux C, Hamidou M, Maurier F, Aumaitre O, Aouba A, Quemeneur T, Subra JF, Cottin V, Sibilia J, Godmer P, Cacoub P, Fauchais AL, Hachulla E, Maucort-Boulch D, Guillevin L, Lega JC; French Vasculitis Study Group (FVSG).

Autoimmun Rev. 2018 Jul;17(7):653-659. doi: 10.1016/j.autrev.2018.01.022. Epub 2018 May 3. Review.

PMID:
29730524
30.

Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis.

Barra L, Yang G, Pagnoux C; Canadian Vasculitis Network (CanVasc).

Autoimmun Rev. 2018 Jul;17(7):683-693. doi: 10.1016/j.autrev.2018.01.019. Epub 2018 May 2. Review.

PMID:
29729444
31.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. Epub 2018 May 3.

PMID:
29724729
32.

Diagnosis and management of ADA2 deficient polyarteritis nodosa.

Human A, Pagnoux C.

Int J Rheum Dis. 2019 Jan;22 Suppl 1:69-77. doi: 10.1111/1756-185X.13283. Epub 2018 Apr 6. Review.

PMID:
29624883
33.

Infection-associated vasculitides.

Haq SA, Pagnoux C.

Int J Rheum Dis. 2019 Jan;22 Suppl 1:109-115. doi: 10.1111/1756-185X.13287. Epub 2018 Apr 6. Review.

PMID:
29624865
34.

Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis.

Springer JM, Monach P, Cuthbertson D, Carette S, Khalidi NA, McAlear CA, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Hoffman G, Langford C, Hamilton T, Foell D, Vogl T, Holzinger D, Merkel PA, Roth J, Hajj-Ali RA.

J Clin Rheumatol. 2018 Oct;24(7):393-395. doi: 10.1097/RHU.0000000000000729. No abstract available.

PMID:
29470262
35.

Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study.

Ing EB, Ing R, Liu X, Zhang A, Torun N, Sey M, Pagnoux C.

Clin Ophthalmol. 2018 Jan 11;12:113-118. doi: 10.2147/OPTH.S151893. eCollection 2018.

36.

Impact of vasculitis on employment and income.

Barra L, Borchin RL, Burroughs C, Casey GC, McAlear CA, Sreih AG, Young K, Merkel PA, Pagnoux C; Vasculitis Clinical Research Consortium and the Vasculitis Patient-Powered Research Network.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):58-64. Epub 2018 Jan 10.

37.

Imaging modalities for the diagnosis and disease activity assessment of Takayasu's arteritis: A systematic review and meta-analysis.

Barra L, Kanji T, Malette J, Pagnoux C; CanVasc.

Autoimmun Rev. 2018 Feb;17(2):175-187. doi: 10.1016/j.autrev.2017.11.021. Epub 2017 Dec 5. Review.

PMID:
29313811
38.

Catastrophic primary angiitis of the central nervous system.

de Boysson H, Pagnoux C.

Eur J Neurol. 2018 Jan;25(1):e3. doi: 10.1111/ene.13469. No abstract available.

PMID:
29271585
39.

Multivariable prediction model for suspected giant cell arteritis: development and validation.

Ing EB, Lahaie Luna G, Toren A, Ing R, Chen JJ, Arora N, Torun N, Jakpor OA, Fraser JA, Tyndel FJ, Sundaram AN, Liu X, Lam CT, Patel V, Weis E, Jordan D, Gilberg S, Pagnoux C, Ten Hove M.

Clin Ophthalmol. 2017 Nov 22;11:2031-2042. doi: 10.2147/OPTH.S151385. eCollection 2017.

40.

Childhood- versus adult-onset ANCA-associated vasculitides: A nested, matched case-control study from the French Vasculitis Study Group Registry.

Iudici M, Pagnoux C, Quartier P, Büchler M, Cevallos R, Cohen P, de Moreuil C, Guilpain P, Le Quellec A, Serratrice J, Terrier B, Guillevin L, Mouthon L, Puéchal X; French Vasculitis Study Group.

Autoimmun Rev. 2018 Feb;17(2):108-114. doi: 10.1016/j.autrev.2017.11.014. Epub 2017 Nov 24. Review.

PMID:
29180123
41.

Childhood Takayasu arteritis: disease course and response to therapy.

Aeschlimann FA, Eng SWM, Sheikh S, Laxer RM, Hebert D, Noone D, Twilt M, Pagnoux C, Benseler SM, Yeung RSM.

Arthritis Res Ther. 2017 Nov 22;19(1):255. doi: 10.1186/s13075-017-1452-4.

42.

Evaluation of damage in giant cell arteritis.

Kermani TA, Sreih AG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium.

Rheumatology (Oxford). 2018 Feb 1;57(2):322-328. doi: 10.1093/rheumatology/kex397.

43.

Prognostic Significance of Cavitary Lung Nodules in Granulomatosis With Polyangiitis (Wegener's): A Clinical Imaging Study of 225 Patients.

Russell B, Mohan S, Chahal R, Carette S, Pagnoux C.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1082-1089. doi: 10.1002/acr.23443. Epub 2018 May 6.

44.

Reply.

Puéchal X, Pagnoux C, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2018 Jan;70(1):151-152. doi: 10.1002/art.40334. Epub 2017 Nov 28. No abstract available.

45.

Investigational drugs in systemic vasculitis.

Mirouse A, Cacoub P, Desbois AC, Comarmond C, Pagnoux C, Saadoun D.

Expert Opin Investig Drugs. 2017 Sep;26(9):1049-1061. doi: 10.1080/13543784.2017.1361928. Epub 2017 Aug 4. Review.

PMID:
28758504
46.

Concordance of Time-of-Flight MRA and Digital Subtraction Angiography in Adult Primary Central Nervous System Vasculitis.

de Boysson H, Boulouis G, Parienti JJ, Touzé E, Zuber M, Arquizan C, Dequatre N, Detante O, Bienvenu B, Aouba A, Guillevin L, Pagnoux C, Naggara O.

AJNR Am J Neuroradiol. 2017 Oct;38(10):1917-1922. doi: 10.3174/ajnr.A5300. Epub 2017 Jul 27.

47.

Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.

Puéchal X, Pagnoux C, Baron G, Quémeneur T, Néel A, Agard C, Lifermann F, Liozon E, Ruivard M, Godmer P, Limal N, Mékinian A, Papo T, Ruppert AM, Bourgarit A, Bienvenu B, Geffray L, Saraux JL, Diot E, Crestani B, Delbrel X, Sailler L, Cohen P, Le Guern V, Terrier B, Groh M, Le Jeunne C, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Nov;69(11):2175-2186. doi: 10.1002/art.40205. Epub 2017 Oct 15.

48.

Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

Karras A, Pagnoux C, Haubitz M, Groot K, Puechal X, Tervaert JWC, Segelmark M, Guillevin L, Jayne D; European Vasculitis Society.

Ann Rheum Dis. 2017 Oct;76(10):1662-1668. doi: 10.1136/annrheumdis-2017-211123. Epub 2017 May 25.

PMID:
28546260
49.

Variations in the clinical practice of physicians managing Takayasu arteritis: a nationwide survey.

Barra L, Liang P, Benseler SM, Cabral DA, Fifi-Mah A, Li Y, Milman N, Twilt M, Yacyshyn E, Pagnoux C.

Open Access Rheumatol. 2017 May 5;9:91-99. doi: 10.2147/OARRR.S132080. eCollection 2017.

50.

Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.

Samson M, Puéchal X, Mouthon L, Devilliers H, Cohen P, Bienvenu B, Ly KH, Bruet A, Gilson B, Ruivard M, Pertuiset E, Hamidou M, Pagnoux C, Terrier B, Guillevin L; French Vasculitis Study Group (FVSG).

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):176-184. Epub 2017 Apr 18.

Supplemental Content

Loading ...
Support Center